Targeting Folate Receptors in Gliomas: A New Way to Detect Brain Tumors

Recent research conducted by Maxwell Miner from the University of Turku in Finland, working at the Turku PET Centre, sheds light on the potential of folate receptors as a valuable tool in the field of brain tumor imaging and treatment. Folate-based radiopharmaceuticals are a type of medical imaging agent that combines folate – a form of vitamin B9 – with a radioactive substance.

Read More